fbpx
Cellaviva Sverige April 27, 2021

Pediatric diabetes study with stem cells approved

Uppsala University Hospital and the principal investigator, Professor Per-Ola Carlsson, have been granted approval from the Medical Products Agency and the Swedish Ethical Review Authority to conduct a clinical drug trial with ProTrans™ to treat children and adolescents with type-1 diabetes. The study is a phase I / II study with a total of 66 patients.

Prepare for the summer
Prepare for the summer

Are you expecting a summer child with a due date in the holiday season?

If you are planning to order our help with the collection, make sure to order well in advance of your due date.